MALLIK AMEET (CIK 1861441) reported 7 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy ADCT (675,000 shares), Buy ADCT (900,000 shares), Sell ADCT (103,231 shares), Sell ADCT (233,146 shares), Buy ATRA (7,828 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | ADC Therapeutics SA (ADCT) | Chief Executive Officer | Buy | 675,000 | $0 |
| 2026-02-18 | ADC Therapeutics SA (ADCT) | Chief Executive Officer | Buy | 900,000 | $3.6M |
| 2026-02-18 | ADC Therapeutics SA (ADCT) | Chief Executive Officer | Sell | 103,231 | $411,892 |
| 2025-12-09 | ADC Therapeutics SA (ADCT) | Chief Executive Officer | Sell | 233,146 | $767,050 |
| 2025-06-12 | Atara Biotherapeutics, Inc. (ATRA) | Director | Buy | 7,828 | $0 |
| 2025-05-08 | ADC Therapeutics SA (ADCT) | Chief Executive Officer | Sell | 26,758 | $34,518 |
| 2025-02-14 | ADC Therapeutics SA (ADCT) | Chief Executive Officer | Buy | 650,000 | $1.0M |
Source: SEC Form 4 filings · as of 2026-07-02